Generic Name and Formulations:
Hyoscyamine sulfate 0.125mg; sublingual scored tabs; peppermint flavor; dye-free.
- Frequency of Tanning, Risk for Melanoma Higher in Gym Tanners
- SLNBs Feasible After Wide Local Excisions in Melanoma of the Head and Neck
- FDA Grants Priority Review to Duvelisib for CLL/SLL and Follicular Lymphoma
- Irritable Bowel Syndrome (IBS) Treatments
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
- Pharmacokinetics of Atypical Antipsychotics
Indications for LEVSIN/SL:
Adjunct in peptic ulcer. Irritable bowel syndrome. Infant colic.
1–2 tabs sublingually, swallowed, or chewed every 4 hrs or as needed; max 12 tabs/day.
<2yrs: not recommended. ≥2yrs: ½ –1 tab sublingually, swallowed, or chewed every 4 hrs or as needed; max 6 tabs/day.
Glaucoma. Unstable cardiovascular status in acute hemorrhage. GI or urinary tract obstruction. Paralytic ileus, intestinal atony of elderly or debilitated patients. Toxic megacolon. Severe ulcerative colitis. Myasthenia gravis.
High environmental temperature. Diarrhea. Autonomic neuropathy. Impaired cardiac or renal function. Cardiovascular disease. Hypertension. Hyperthyroidism. Hiatal hernia with reflux esophagitis. Pregnancy (Cat.C). Nursing mothers.
Antacids may inhibit absorption. Additive anticholinergic effects with other anticholinergics, amantadine, type I antiarrhythmics, antihistamines, phenothiazines, tricyclics, MAOIs.
Anticholinergic effects, drowsiness.
Formerly known under the brand name Levsin Drops.
Tabs, SL—100, 500; Drops—contact supplier
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- IL-23 Drives Castration-Resistant Prostate Cancer
- Immediate Instillation of Mitomycin C Post-TURBT May Benefit All Patients with Bladder Cancer
- Lenalidomide-Based Maintenance Therapy May Be the Most Effective in Myeloma
- Approximately Two-Thirds of Patients With Stage IV Bladder Cancer Remain Untreated
- Aspirin and Colorectal Cancer